Anti-Doping Control Using Comprehensive Multidimensional Gas Chromatography Time-of-Flight Mass Spectrometry (GCxGC-TOFMS) for Enhanced Detection of Anabolic Steroids in Urine

Importance of the Topic

Urine-based steroid screening is pivotal in anti-doping control to ensure fair competition. The complexity of urinary matrices and low analyte concentrations require analytical methods with high resolution and sensitivity. Comprehensive two-dimensional gas chromatography coupled with time-of-flight mass spectrometry (GCxGC-TOFMS) offers enhanced peak capacity and rapid data acquisition, enabling reliable detection of trace anabolic steroids.

Objectives and Study Overview

This study aimed to demonstrate the capabilities of GCxGC-TOFMS for anti-doping analysis by:

• Resolving steroid analytes that coelute in one-dimensional chromatography
• Achieving detection limits at or below World Anti-Doping Agency cut offs (2 ng/mL)
• Evaluating quantitative performance across a calibration range of 2 to 100 ng/mL

Methodology and Instrumentation

Urine samples were spiked with five trimethylsilyl-derivatized steroid standards at concentrations ranging from 2 to 100 ng/mL. Sample preparation involved:

• Acid hydrolysis with beta glucuronidase at 50°C for one hour
• pH adjustment and liquid–liquid extraction with methyl tert butyl ether
• Drying under nitrogen followed by derivatization with MSTFA NH4I ethanethiol

Instrumentation used:

• Gas chromatograph with dual stage thermal modulator and automated sampler
• Primary column Rxi-5ms (30 m × 0.25 mm × 0.25 μm) and secondary column BPX-50 (1.20 m × 0.10 mm × 0.10 μm)
• Time-of-flight mass spectrometer Pegasus 4D operating at 100 spectra per second over 45 to 750 m/z

Key Results and Discussion

• Enhanced peak capacity of GCxGC fully resolved coeluting TMS derivatives of stanozolol and hydroxystanozolols
• True signal deconvolution separated trace anabolic steroids from endogenous interferences, enabling clear spectral identification
• Calibration curves of di- and tri-TMS derivatives exhibited linearity greater than 99.9% over 2–100 ng/mL
• Limits of detection at or below 2 ng/mL were achieved for all five target steroids, meeting or exceeding WADA minimum required performance levels

Benefits and Practical Applications

GCxGC-TOFMS offers:

• Significantly improved resolution in complex biological samples
• Reliable detection and quantification of anabolic steroids at ultra-trace levels
• Automated deconvolution for simultaneous qualitative and quantitative analysis in a single run

Future Trends and Opportunities

Potential developments include:

• Integration of high-resolution accurate mass spectrometry to further enhance selectivity
• Advancements in modulation technology to increase throughput and peak capacity
• Application of machine learning algorithms for automated data interpretation and deconvolution

Conclusion

This study demonstrates that GCxGC-TOFMS significantly improves the detection, separation, and quantitation of anabolic steroids in urine compared to one-dimensional GCMS. The method reliably meets stringent WADA guidelines, offering robust performance for routine anti-doping laboratories.

References

• John Heim, Doug Staples, Joe Binkley. Anti-Doping Control Using GCxGC-TOFMS for Enhanced Detection of Anabolic Steroids in Urine. LECO Corporation.